{
  "slug": "flatiron-health-roche",
  "name": "flatiron-health-roche",
  "description": "Flatiron Health provides oncology-focused electronic health record (EHR) software and maintains a robust repository of real-world cancer data. The company partners with cancer centers, community oncology practices, and pharmaceutical developers to leverage real-world evidence to accelerate cancer treatment development and improve patient care. It specializes in curating high-quality data from hard-to-access sources.",
  "url": "https://optimly.ai/brand/flatiron-health-roche",
  "websiteUrl": "https://fiercehealthcare.com/",
  "logoUrl": "https://logo.clearbit.com/fiercehealthcare.com",
  "baiScore": 43,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": "Incumbent",
  "archetype_status": "active",
  "category": "Health Tech",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-08-09T00:02:46.321Z",
  "verifiedVitals": {
    "website": "https://fiercehealthcare.com",
    "founded": "2012",
    "headquarters": "Not explicitly stated (operations in Japan, Germany, U.K.)",
    "pricing_model": "Not specified (likely subscription-based for software/data access and service-based for collaborations/consulting).",
    "core_products": "Oncology-focused electronic health record (EHR) software, curated real-world cancer data repositories, clinical trial technology integration.",
    "key_differentiator": "Specialization in oncology, expertise in extracting and curating high-quality real-world data from hard-to-access sources, and integrating this data into EHR and clinical trial workflows to generate regulatory-grade real-world evidence.",
    "target_markets": "Cancer centers, community oncology practices, global oncology therapeutic developers, pharmaceutical companies, healthcare organizations, academic institutions, regulatory bodies (e.g., FDA).",
    "employee_count": "Not mentioned",
    "funding_stage": "Acquired (by Roche in 2018), previously backed by Alphabet.",
    "subcategory": "Oncology Data & Analytics"
  },
  "intentTags": {
    "problemIntents": [
      "Traditional Clinical Trials: Reliance solely on prospective, randomized controlled trials (RCTs) for drug development and regulatory approval, which can be time-consuming and costly, without leveragin",
      "Specialized CROs (Clinical Research Organizations): Outsourcing the design, execution, and data management of oncology clinical trials to third-party organizations that may or may not specialize in re",
      "Maintain Data Silos: Continuing to operate with fragmented clinical and real-world data, hindering comprehensive insights, slowing down research and development, and missing opportunities for personal"
    ],
    "solutionIntents": [
      "Flatiron Health oncology data",
      "Roche selling Flatiron Health",
      "Flatiron Health real world evidence partnerships",
      "General Purpose EHR Systems & Data Vendors: Using broad electronic health record systems that lack specialized oncology-specific data curation and analysis capabilities, or relying on general data ven"
    ],
    "evaluationIntents": []
  },
  "businessProfileClaims": [],
  "timestamp": 1786529920711
}